CHOLESTEROL AND CHLORIDE IN ACUTE HEART FAILURE

Bojana Radulović1, Ines Potočnjak1, Sanda Dokoza Terešak1

  • 11Zagreb University Hospital Centre, Zagreb, Croatia; 2Sestre milosrdnice University Hospital Centre, Zagreb, Croatia; 3University of Zagreb School of Medicine, Zagreb, Croatia; 4University of Zagreb Faculty of Pharmacy and Biochemistry, Zagreb, Croatia; 5Occupational Medicine Office, Zagreb, Croatia; 6Sveti Duh University Hospital, Zagreb, Croatia; 7Andrija Štampar School of Public Health, University of Zagreb School of Medicine, Zagreb, Croatia; 8Institute of Molecular Biology and Biochemistry, Centre of Molecular Medicine, Medical University of Graz, Graz, Austria.

Acta Clinica Croatica
|December 11, 2019
PubMed

Insights

Serum chloride and cholesterol levels, including total cholesterol and LDL-c, are linked to survival in acute heart failure patients. Higher levels of these markers at admission predict better hospital and 3-month survival outcomes.

Area of Science:

  • Cardiology
  • Clinical Chemistry

Background:

  • Low serum lipid levels are known predictors of poor outcomes in heart failure (HF).
  • Understanding predictors of poor outcomes is crucial for developing new therapeutic strategies in HF.

Purpose of the Study:

  • To investigate the association between serum lipid and chloride concentrations.
  • To determine the impact of these concentrations on survival in patients with acute heart failure (AHF).

Main Methods:

  • Prospective, single-centre, observational study.
  • Inclusion of 152 patients diagnosed with AHF.
  • Statistical analysis using Spearman's correlation and binary logistic regression.

Main Results:

  • Significant positive correlations were found between serum chloride and total cholesterol, LDL-c, and HDL-c levels.
  • Serum levels of chloride, total cholesterol, and LDL-c at admission were significantly associated with improved hospital survival.
  • These markers were also significantly associated with improved 3-month survival.

Conclusions:

  • A positive statistical association exists between serum cholesterol (total, LDL-c, HDL-c) and chloride levels in AHF.
  • These findings suggest similar modulation of these markers by AHF pathophysiology.
  • Serum levels of total cholesterol, LDL-c, and chloride are identified as contributors to patient survival in AHF.

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
755
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
624
Roles of Electrolytes: Chloride and Bicarbonate01:29

Roles of Electrolytes: Chloride and Bicarbonate

Chloride ions contribute to the osmotic pressure gradient distinguishing the intracellular fluid (ICF) from the extracellular fluid (ECF). They counterbalance positively charged ions in the ECF and ensure its electrochemical stability. The renal system's process of chloride absorption and release generally mirrors that of sodium ions.
Conditions such as hypochloremia can arise from insufficient chloride reabsorption by the kidneys, often compounded by extended bouts of diarrhea, vomiting,...
860
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
216
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
852
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
179